Literature DB >> 341733

The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery.

C Brass, G K Richards, J Ruedy, J Prentis, E J Hinchey.   

Abstract

A prospective randomized clinical trial assessing the relative effectiveness of erythromycin-neomycin and metronidazole-neomycin as a preoperative bowel preparation was carried out. Bacteriologic studies of feces and colon content revealed no significant difference in the reduction of aerobic bacteria between the two groups. There was, however, a significantly greater reduction in anaerobic bacteria in the feces and colon contents of patients receiving metronidazole. Wound infection rate was 25% in the erythromycin group, and organisms recovered from the wound in all cases were fecal in nature. Two wound infections occurred in the metronidazole group (5%) and in both cases the organisms recovered were staphylococci of presumed skin origin. These studies suggest that anaerobic bacteria are the major contributors to wound infection after colon surgery and that their specific reduction is associated with a lower incidence of wound infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 341733     DOI: 10.1016/0002-9610(78)90016-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Common bacterial infections in infancy and childhood. 4. Skin and wound infections.

Authors:  M I Marks
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

2.  Advances in antibiotic prophylaxis in gastrointestinal surgery.

Authors:  R T Lewis
Journal:  Can Med Assoc J       Date:  1979-08-04       Impact factor: 8.262

3.  Quality of use of parenteral metronidazole therapy in a teaching hospital.

Authors:  P J Jewesson; R L Bachand; G A Bell; R J Ensom; A W Chow
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

4.  Intestinal antisepsis: rationale and results.

Authors:  R E Condon
Journal:  World J Surg       Date:  1982-03       Impact factor: 3.352

5.  Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery.

Authors:  C Martin; B Bruguerolle; M N Mallet; M Condomines; B Sastre; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 6.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

7.  Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery.

Authors:  C Martin; B Sastre; M N Mallet; B Bruguerolle; J P Brun; P De Micco; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

8.  The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery.

Authors:  Y M Dion; G K Richards; J J Prentis; E J Hinchey
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.